JPRN-UMIN000020200尚未招募未知
The efficacy of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors for pericardial fat in the type 2 diabetes patients - The efficacy of SGLT2 inhibitors for pericardial fat in the type 2 diabetes patients
ational Hospital Organization Takasaki General Medical Center0 个研究点目标入组 30 人开始时间: 2015年12月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with decreased renal function. 2)Patient corresponding to the contraindications and careful administration of SGLT2 inhibitors. 3)Patients research investigator has determined to be inappropriate as a patient.
研究者
相似试验
已完成
不适用
Efficacy and safety of sodium-glucose cotransporter-2 inhibitor in patients with type 2 diabetesType 2 diabetes mellitusJPRN-UMIN000017625Department of Cardiology, Fukuoka University Hospital.50
已完成
不适用
Effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000018367Ise Red Cross Hospital Department of Metabolic Diseases30
招募中
不适用
Efficacy and safety of sodium-glucose co-transporter (SGLT2) inhibitor in diabetic patients with chronic liver diseaseDiabetic patients with chronic liver diseaseJPRN-UMIN000035015Kitasato University School of Medicine100
招募中
不适用
Efficacy and safety of sodium-glucose co-transporter (SGLT2) inhibitor in diabetic patients post renal transplantatioDiabetic patients after kidney transplantJPRN-UMIN000033628Tokyo Women's Medical University School of Medicine15
招募中
不适用
Effects of an Inhibitor of Sodium-glucose Cotransporter 2 for Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease (NAFLD).Patients of type 2 diabetes mellitus with nonalcoholic fatty liver disease (NAFLD).JPRN-UMIN000020615Department of Endocrinology, Diabetes and Metabolism, Kitasato University School of Medicine.20